Aurobindo Pharma Limited is one of the major pharmaceutical companies located in Hyderabad, India. P.V. Ramprasad Reddy and K. Nityananda Reddy founded it in 1986. The company focuses on the production of medications and active pharmaceutical ingredients presented as generics. Aurobindo Pharma has established itself as the pioneering global manufacturer of generic medications.
The company offers a wide range of products in the major therapeutic areas, specifically antibacterials, antiretrovirals, cardiovascular, central nervous system, gastroenterology, and antidiabetics. Aurobindo Pharma is characterized by a broad-based manufacturing presence, as many of its facilities across India and some foreign plants comply with the leading international quality standards.
Financial Data Analysis Of Aurobindo Pharma’s
As of May 2024, Aurobindo Pharma’s financial ratios include:
- Aurobindo Pharma’s PE ratio is approximately 24.92. This ratio enables investors to assess the stock price taking into account the organization’s earnings per share on a trailing twelve-month basis.
- The current ratio of Aurobindo Pharma, based on the most recent data available, is about 1.55. This state measures a company’s ability to clear its short-term liabilities using its current short-term assets, and a current ratio higher than 1 means that the company has more than enough liquid current assets to pay its current liabilities.
For the most recent and detailed financial metrics, reviewing Aurobindo Pharma’s quarterly or annual financial reports via their investor relations page or financial analysis platforms would provide the most accurate insights.
| Starting Month | End Of Month | |
| January | 1080.15 | 1150.40 |
| February | 1070.80 | 1028.10 |
| March | 1026.40 | 1088.75 |
| April | 1113.35 | 1153.50 |
| May | 5997.87 | 6025.67 |
| June | 6025.67 | 6043.84 |
| July | 6043.84 | 6059.30 |
| August | 6059.30 | 6070.32 |
| September | 6070.32 | 6084.95 |
| October | 6084.95 | 6095.26 |
| November | 6095.26 | 6114.25 |
| December | 6114.25 | 6127.80 |
| Starting Month | End Of Month | |
| January | 6127.80 | 6139.39 |
| February | 6139.39 | 6150.58 |
| March | 6150.58 | 6163.64 |
| April | 6163.64 | 6177.57 |
| May | 6177.57 | 6170.33 |
| June | 6170.33 | 6183.55 |
| July | 6183.55 | 6196.21 |
| August | 6196.21 | 6213.47 |
| September | 6213.47 | 6226.60 |
| October | 6226.60 | 6240.51 |
| November | 6240.51 | 6249.47 |
| December | 6249.47 | 6260.41 |
| Starting Month | End Of Month | |
| January | 6260.41 | 6274.58 |
| February | 6260.41 | 6285.48 |
| March | 6285.48 | 6298.54 |
| April | 6298.54 | 6315.41 |
| May | 6315.41 | 6328.44 |
| June | 6328.44 | 6340.65 |
| July | 6340.65 | 6338.58 |
| August | 6338.58 | 6348.65 |
| September | 6348.65 | 6358.25 |
| October | 6358.25 | 6370.42 |
| November | 6370.42 | 6381.72 |
| December | 6381.72 | 6393.36 |
| Starting Month | End Of Month | |
| January | 6393.36 | 6412.80 |
| February | 6412.80 | 6426.54 |
| March | 6426.54 | 6440.63 |
| April | 6440.63 | 6461.72 |
| May | 6461.72 | 6451.42 |
| June | 6451.42 | 6468.32 |
| July | 6468.32 | 6474.54 |
| August | 6474.54 | 6485.87 |
| September | 6485.87 | 6498.69 |
| October | 6498.69 | 6513.55 |
| November | 6513.55 | 6526.32 |
| December | 6526.32 | 6534.43 |
| Starting Month | End Of Month | |
| January | 6534.43 | 6548.68 |
| February | 6548.68 | 6559.74 |
| March | 6559.74 | 6570.40 |
| April | 6570.40 | 6583.65 |
| May | 6583.65 | 6599.38 |
| June | 6599.38 | 6613.66 |
| July | 6613.66 | 6626.47 |
| August | 6626.47 | 6642.98 |
| September | 6642.98 | 6650.47 |
| October | 6650.47 | 6665.21 |
| November | 6665.21 | 6658.49 |
| December | 6658.49 | 6668.25 |
FAQs
- What is the Aurobindo Pharma share price target for 2025?
- The target is ₹6260.41.
- What is the Aurobindo Pharma share price target for 2026?
- The target is ₹6300.
- What is the Aurobindo Pharma share price target for 2027?
- The target is ₹6400.
- What is the Aurobindo Pharma share price target for 2028?
- The target is ₹6393.36.
- What is the Aurobindo Pharma share price target for 2030?
- The target is ₹6534.43.
- What is the Aurobindo Pharma share price target for 2031?
- The target is ₹6600.
- What is the Aurobindo Pharma share price target for 2035?
- The target is ₹6668.25.
- What is the Aurobindo Pharma share price target for 2040?
- The target is ₹6758.15.
Also Check